SCHEMBL10426023

SCHEMBL10426023

CCN(CC)CCOc1ccc(N)cc1C(=O)C=Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 7/20 0.59
▸ ACHE P22303 7/20 0.59
▸ MAOB P27338 4/20 0.53
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ SCN1A P35498 1/20 0.48
▸ SCN2A Q99250 1/20 0.48
▸ SCN3A Q9NY46 1/20 0.48
▸ MAOA P21397 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10426021 0.83 BCHE (0.55) BCHEACHEMAOBKDM4EALDH1A1
SCHEMBL10426020 0.83 BCHE (0.55) BCHEACHEMAOBKDM4EALDH1A1
Bromide SCHEMBL10426109 0.83 BCHE (0.54) BCHEACHEMAOBKDM4EALDH1A1
Bromide SCHEMBL10426111 0.83 BCHE (0.54) BCHEACHEMAOBKDM4EALDH1A1
SCHEMBL10426725 0.82 BCHE (0.53) BCHEACHEMAOBKDM4EALDH1A1
Bromide SCHEMBL10425849 0.81 BCHE (0.53) BCHEACHEMAOBKDM4EALDH1A1
SCHEMBL10589183 0.81 KDM4E (0.55) KDM4EALDH1A1LMNACYP1A2CYP2D6
SCHEMBL6803941 0.79 KDM4E (0.61) MAOBKDM4EALDH1A1LMNACYP1A2
Bromide SCHEMBL10426263 0.78 KDM4E (0.60) MAOBKDM4EALDH1A1LMNACYP1A2
SCHEMBL10426054 0.77 ABCB1 (0.52) KDM4EALDH1A1LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4906634-A Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents SCHERING A.G. (DE) 1990-03-06 — — US disclosed
EP-0332570-A2 Novel-N-(4-(Aminosubstituted)phenyl) methanesulfonamides and their use as cardiovascular agents SCHERING AKTIENGESELLSCHAFT (DE) 1989-09-13 — — EP disclosed
Send feedback